Healthy intakes of n-3 and n-6 fatty acids: estimations considering
worldwide diversity
Joseph R Hibbeln, Levi RG Nieminen, Tanya L Blasbalg, Jessica A Riggs, and William EM Lands
ABSTRACT
Background: The worldwide diversity of dietary intakes of n6 and n3 fatty acids influences tissue compositions of n3 longchain fatty acids (LCFAs: eicosapentaenoic, docosapentaenoic, and docosahexaenoic acids) and risks of cardiovascular and mental illnesses.
Objective: We aimed to estimate healthy dietary allowances for n3 LCFAs that would meet the nutrient requirements of 97–98% of the population.
Design: Deficiency in n3 LCFAs was defined as attributable risk from 13 morbidity and mortality outcomes, including all causes, coronary heart disease, stroke, cardiovascular disease, homicide,
bipolar disorder, and major and postpartum depressions. Dietary availability of n3 LCFAs from commodities for 38 countries and tissue composition data were correlated by best fit to each illness in
deficiency risk models.
Results: The potential attributable burden of disease ranged from 20.8% (all-cause mortality in men) to 99.9% (bipolar disorder). n3 LCFA intake for Japan (0.37% of energy, or 750 mg/d) met criteria
for uniformly protecting 98% of the populations worldwide. n3 LCFA intakes needed to meet a tissue target representative of Japan (60% n3 in LCFA) ranged from 278 mg/d (Philippines, with intakes of 0.8%of energy as linoleate, 0.08%of energy as -linolenate, and 0.06% of energy as arachidonic acid) to 3667 mg/d (United States, with 8.91% of energy as linoleate, 1.06% of energy as - linolenate, and 0.08% of energy as arachidonic acid).
Conclusions: With caveats inherent for ecologic, nutrient disappearance analyses, a healthy dietary allowance for n3 LCFAs for current US diets was estimated at 3.5 g/d for a 2000-kcal diet.
This
allowance for n3 LCFAs can likely be reduced to one-tenth of that amount by consuming fewer n6 fats.
Bookmarks